Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Signs on IDEC Pharmaceuticals as Database Subscriber

NEW YORK, Jan 8 – Gene Logic has signed on IDEC pharmaceuticals, a developer of antibody therapeutics, as a multi-year subscriber to its GeneExpress Oncology DataSuite, Gene Logic announced Monday.

IDEC will use the database to discover and develop cancer therapeutics. The database provides disease-specific gene expression profiles for a number of human cancer types . The system will be deployed, along with Gene Logic’s GX2000 software, throughout the company’s R&D unit.

Financial terms of the subscription agreement were not disclosed.

“We are very pleased to establish a partnership with IDEC Pharmaceuticals to support their focused research on cancer," Gene Logic CEO Mark Gessler said in a statement. " This partnership strengthens and further validates our ongoing strategy of delivering targeted solutions that address the specialized needs of our pharmaceutical and biotechnology customers as they pursue genomics-driven drug development initiatives."

Gene Logic has recently signed as subscribers to its databases Organon, Boehringer Ingelheim Pharmaceuticals, Biogen, Proctor & Gamble,

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.